JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, cilt.38, sa.2, ss.322-330, 2001 (SCI-Expanded)
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent.